Welcome to our dedicated page for Olaplex Holdings SEC filings (Ticker: OLPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Olaplex Holdings, Inc. (NASDAQ: OLPX), a science-enabled, technology-driven beauty company focused on hair health and bond-building formulations. Through these filings, investors can review how Olaplex reports on its operations, financial condition and key risks as a manufacturer in the toilet preparation and broader health and beauty space.
Olaplex’s SEC submissions include annual reports on Form 10-K, which typically contain detailed discussions of its omnichannel business model spanning professional, specialty retail and direct-to-consumer channels, as well as risk factors such as competition in the beauty industry, brand perception, international operations and indebtedness. Quarterly reports on Form 10-Q provide interim financial statements and management’s discussion of recent performance, including net sales trends and the use of non-GAAP measures like adjusted EBITDA and adjusted gross profit, as described in the company’s earnings releases.
The company also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered quarterly results and the stock purchase agreement through which a subsidiary acquired Purvala Bioscience, a biotech company developing bioinspired technologies for health and beauty applications, as well as board appointments. For those monitoring insider activity, Form 4 filings (when available) report changes in beneficial ownership by directors, officers and other insiders.
On Stock Titan, these documents are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain lengthy sections of 10-K and 10-Q filings, highlight key items in 8-K disclosures, and make it easier to understand topics like non-GAAP reconciliations, risk factors and significant agreements. This allows users to quickly navigate Olaplex’s regulatory history, from its bond-focused haircare strategy to corporate transactions and governance developments, without reading every page of each filing.
Olaplex (NASDAQ: OLPX) filed a routine Form 4 on June 29, 2025. The filing states that former director Paula Zusi ceased serving on the board effective June 10, 2025 and is therefore no longer subject to Section 16 reporting requirements. No purchases, sales, or other equity transactions were disclosed, and the tables for both non-derivative and derivative securities list no entries. The document is filed voluntarily to formally register Ms. Zusi’s change in reporting status.
Because the Form 4 reports no share transactions or monetary amounts, it represents an administrative update rather than a market-moving event.